Showing results (81-90 of 1,242) with videos related to

Sort By:
Pageof 125
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 2, 2026
Homozygosity for the C allele at UNC13A rs12608932 seems to compromise cognition in ALS independently of the cognitive domainsAnnaliis Lehto, Andreas Zapf, Andreas Hermann, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 30, 2018
The Edinburgh Cognitive and Behavioral ALS screen: relationship to age, education, IQ and the Addenbrooke's Cognitive Examination-IIIMónica M De Icaza Valenzuela, Thomas H Bak, Suvankar Pal, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 7, 2018
Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone diseaseDaniela K Schlüter, Alan Tennant, Roger Mills, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 30, 2016
Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI)Marwa Elamin, Marta Pinto-Grau, Tom Burke, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 30, 2016
Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative dataMarta Pinto-Grau, Tom Burke, Katie Lonergan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 29, 2016
The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuationC Flaherty, J Kraft, A Brothers, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2016
Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian Research CenterGerson Chadi, Jessica Ruivo Maximino, Frederico Mennucci de Haidar Jorge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 5, 2014
Predicting success: optimizing phase II ALS trials for the transition to phase IIIJames D Berry, Merit E Cudkowicz, Jeremy M Shefner
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 30, 2014
Opportunities for improving therapy development in ALSLucie Bruijn, Merit Cudkowicz,
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 12, 2014
Multiple system involvement in a Japanese patient with a V31A mutation in the SOD1 geneHikaru Sakamoto, Maiko Akamatsu, Makito Hirano, et al.
Pageof 125